REPLY: SCORPION study: is it time to call primary debulking surgery superior?
- PMID: 33443034
- DOI: 10.1136/ijgc-2020-002295
REPLY: SCORPION study: is it time to call primary debulking surgery superior?
Keywords: ovarian cancer.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).Int J Gynecol Cancer. 2020 Nov;30(11):1657-1664. doi: 10.1136/ijgc-2020-001640. Epub 2020 Oct 7. Int J Gynecol Cancer. 2020. PMID: 33028623 Clinical Trial.
-
SCORPION study: is it time to call primary debulking surgery superior?Int J Gynecol Cancer. 2021 Feb;31(2):310. doi: 10.1136/ijgc-2020-002214. Epub 2020 Dec 18. Int J Gynecol Cancer. 2021. PMID: 33443028 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
